Literature DB >> 3492876

Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy.

R Greene, S Lind, H Jantsch, R Wilson, K Lynch, R Jones, A Carvalho, L Reid, A C Waltman, W Zapol.   

Abstract

IV streptokinase was infused to test the potential reversibility of adult respiratory distress syndrome (ARDS) associated pulmonary vascular thrombosis in five patients suffering from severe ARDS with elevated mean pulmonary artery pressure, increased pulmonary vascular resistance, and angiographically documented pulmonary vascular thrombosis. At 48 hr there was clearance of obstructions in arteries larger than 1 mm in diameter in all patients, increased filling of the microvasculature and small arteries less than 1 mm in diameter in four patients, a fall in pulmonary vascular resistance in all patients, a rise in cardiac output in four patients, improved oxygenation (PAO2/FlO2) in three patients, and variable changes in shunt fraction and ventilator pressures. Expressed as a mean fraction of the preinfusion controls, the postinfusion physiologic values were pulmonary artery pressure = 0.89 mm Hg, pulmonary vascular resistance = 0.68 mm Hg X min/L, cardiac output = 1.36 L/min, central venous pressure = 0.77 cm H2O, pulmonary capillary wedge pressure = 0.92 mm Hg, PAO2/FlO2 = 1.08, and shunt fraction = 0.95. Follow-up angiography showed no evidence of reocclusion. Postmortem studies of the three nonsurvivors confirmed recanalization of thrombosed pulmonary arteries. One documented bleeding episode occurred. We conclude that fibrinolytic infusion can lyse thrombi and possibly improve hemodynamics and oxygenation in ARDS-associated pulmonary vascular thrombosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492876     DOI: 10.2214/ajr.148.3.501

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  22 in total

1.  CT predictors of mortality in pathology confirmed ARDS.

Authors:  Jonathan H Chung; Richard L Kradin; Reginald E Greene; Jo-Anne O Shepard; Subba R Digumarthy
Journal:  Eur Radiol       Date:  2010-10-07       Impact factor: 5.315

Review 2.  Pathophysiology of pulmonary hypertension in acute lung injury.

Authors:  Laura C Price; Danny F McAuley; Philip S Marino; Simon J Finney; Mark J Griffiths; Stephen John Wort
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-13       Impact factor: 5.464

3.  The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations.

Authors:  P Krafft; P Fridrich; T Pernerstorfer; R D Fitzgerald; D Koc; B Schneider; A F Hammerle; H Steltzer
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

Review 4.  What is the clinical significance of pulmonary hypertension in acute respiratory distress syndrome? A review.

Authors:  P S Lai; C Mita; B T Thompson
Journal:  Minerva Anestesiol       Date:  2013-10-31       Impact factor: 3.051

5.  HA-1A in septic patients with ARDS: results from the pivotal trial.

Authors:  L M Bigatello; R E Greene; C L Sprung; E A Panacek; R C Straube; J L Zimmerman; R J Maunder; P N Lanken; E Pile-Spellmann; K S Stanek
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

6.  Right Ventricular Strain Is Common in Intubated COVID-19 Patients and Does Not Reflect Severity of Respiratory Illness.

Authors:  Lauren E Gibson; Raffaele Di Fenza; Min Lang; Martin I Capriles; Matthew D Li; Jayashree Kalpathy-Cramer; Brent P Little; Pankaj Arora; Ariel L Mueller; Fumito Ichinose; Edward A Bittner; Lorenzo Berra; Marvin G Chang
Journal:  J Intensive Care Med       Date:  2021-03-30       Impact factor: 3.510

7.  Acute respiratory distress syndrome: A clinical review.

Authors:  Michael Donahoe
Journal:  Pulm Circ       Date:  2011 Apr-Jun       Impact factor: 3.017

8.  Postintubation Decline in Oxygen Saturation Index Predicts Mortality in COVID-19: A Retrospective Pilot Study.

Authors:  Ala Nozari; Shivali Mukerji; Molly Vora; Alfonso Garcia; Alyssa Park; Nicholas Flores; Robert Canelli; Gerardo Rodriguez; Riccardo Pinciroli; Alexander Nagrebetsky; Rafael Ortega; Sadeq A Quraishi
Journal:  Crit Care Res Pract       Date:  2021-05-26

9.  Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study.

Authors:  J-L Diehl; N Peron; R Chocron; B Debuc; E Guerot; C Hauw-Berlemont; B Hermann; J L Augy; R Younan; A Novara; J Langlais; L Khider; N Gendron; G Goudot; J-F Fagon; T Mirault; D M Smadja
Journal:  Ann Intensive Care       Date:  2020-07-16       Impact factor: 6.925

Review 10.  COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.

Authors:  David M Smadja; Steven J Mentzer; Michaela Fontenay; Mike A Laffan; Maximilian Ackermann; Julie Helms; Danny Jonigk; Richard Chocron; Gerald B Pier; Nicolas Gendron; Stephanie Pons; Jean-Luc Diehl; Coert Margadant; Coralie Guerin; Elisabeth J M Huijbers; Aurélien Philippe; Nicolas Chapuis; Patrycja Nowak-Sliwinska; Christian Karagiannidis; Olivier Sanchez; Philipp Kümpers; David Skurnik; Anna M Randi; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2021-06-28       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.